{"id":"https://openalex.org/W4393072067","doi":"https://doi.org/10.1158/1538-7445.am2024-5758","title":"Abstract 5758: Gold nanoparticles with graphene quantum dots as drug delivery platforms for anticancer applications","display_name":"Abstract 5758: Gold nanoparticles with graphene quantum dots as drug delivery platforms for anticancer applications","publication_year":2024,"publication_date":"2024-03-22","ids":{"openalex":"https://openalex.org/W4393072067","doi":"https://doi.org/10.1158/1538-7445.am2024-5758"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2024-5758","doi":"https://doi.org/10.1158/1538-7445.am2024-5758","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-5758","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111152038","display_name":"Fabiola M. Rosa Su\u00e1rez","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1662191","display_name":"University of Puerto Rico at R\u00edo Piedras","ror":"https://ror.org/0453v4r20","country_code":"PR","type":"education","lineage":["https://openalex.org/I1662191","https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Fabiola M. Rosa Su\u00e1rez","raw_affiliation_strings":["1Universidad de Puerto Recinto de R\u00edo Piedras, San Juan, Puerto Rico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Universidad de Puerto Recinto de R\u00edo Piedras, San Juan, Puerto Rico;","institution_ids":["https://openalex.org/I1662191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066612752","display_name":"Gerardo Morell","orcid":"https://orcid.org/0000-0003-4787-2239","observed_orcids":["https://orcid.org/0000-0003-4787-2239"]},"institutions":[{"id":"https://openalex.org/I1662191","display_name":"University of Puerto Rico at R\u00edo Piedras","ror":"https://ror.org/0453v4r20","country_code":"PR","type":"education","lineage":["https://openalex.org/I1662191","https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Gerardo Morell","raw_affiliation_strings":["2Universidad de Puerto Rico Recinto de R\u00edo Piedras, San Juan, Puerto Rico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Universidad de Puerto Rico Recinto de R\u00edo Piedras, San Juan, Puerto Rico","institution_ids":["https://openalex.org/I1662191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5029412939","display_name":"Brad R. Weiner","orcid":"https://orcid.org/0000-0002-5255-1918","observed_orcids":["https://orcid.org/0000-0002-5255-1918"]},"institutions":[{"id":"https://openalex.org/I1662191","display_name":"University of Puerto Rico at R\u00edo Piedras","ror":"https://ror.org/0453v4r20","country_code":"PR","type":"education","lineage":["https://openalex.org/I1662191","https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Brad Weiner","raw_affiliation_strings":["1Universidad de Puerto Recinto de R\u00edo Piedras, San Juan, Puerto Rico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Universidad de Puerto Recinto de R\u00edo Piedras, San Juan, Puerto Rico;","institution_ids":["https://openalex.org/I1662191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5092243817","display_name":"Nataniel Medina-Berr\u00edos","orcid":"https://orcid.org/0000-0002-4507-2687","observed_orcids":["https://orcid.org/0000-0002-4507-2687"]},"institutions":[{"id":"https://openalex.org/I1662191","display_name":"University of Puerto Rico at R\u00edo Piedras","ror":"https://ror.org/0453v4r20","country_code":"PR","type":"education","lineage":["https://openalex.org/I1662191","https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Nataniel Medina","raw_affiliation_strings":["2Universidad de Puerto Rico Recinto de R\u00edo Piedras, San Juan, Puerto Rico"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Universidad de Puerto Rico Recinto de R\u00edo Piedras, San Juan, Puerto Rico","institution_ids":["https://openalex.org/I1662191"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5094090256","display_name":"Wenndy Pantoja\u2010Romero","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1662191","display_name":"University of Puerto Rico at R\u00edo Piedras","ror":"https://ror.org/0453v4r20","country_code":"PR","type":"education","lineage":["https://openalex.org/I1662191","https://openalex.org/I200399037"]}],"countries":["PR"],"is_corresponding":false,"raw_author_name":"Wenndy Pantoja","raw_affiliation_strings":["1Universidad de Puerto Recinto de R\u00edo Piedras, San Juan, Puerto Rico;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Universidad de Puerto Recinto de R\u00edo Piedras, San Juan, Puerto Rico;","institution_ids":["https://openalex.org/I1662191"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I1662191"],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"84","issue":"6_Supplement","first_page":"5758","last_page":"5758"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},"topics":[{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","score":0.9434000253677368,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12627","display_name":"Graphene and Nanomaterials Applications","score":0.02410000003874302,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10782","display_name":"Nanoplatforms for cancer theranostics","score":0.01640000008046627,"subfield":{"id":"https://openalex.org/subfields/2204","display_name":"Biomedical Engineering"},"field":{"id":"https://openalex.org/fields/22","display_name":"Engineering"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/gold-nanoparticles","display_name":"gold nanoparticles","score":0.9919999837875366},{"id":"https://openalex.org/keywords/graphene-quantum-dots","display_name":"graphene quantum dots","score":1.0},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.8510000109672546},{"id":"https://openalex.org/keywords/drug-delivery","display_name":"drug delivery","score":0.824999988079071},{"id":"https://openalex.org/keywords/prostate-cancer","display_name":"prostate cancer","score":0.9800000190734863},{"id":"https://openalex.org/keywords/pc-3-cells","display_name":"PC-3 cells","score":0.7110000252723694},{"id":"https://openalex.org/keywords/hydrophobic-drug-solubility","display_name":"hydrophobic drug solubility","score":0.7570000290870667},{"id":"https://openalex.org/keywords/ic50","display_name":"IC50","score":0.7039999961853027},{"id":"https://openalex.org/keywords/red-blood-cell-morphology","display_name":"erythrocyte morphology","score":0.8140000104904175},{"id":"https://openalex.org/keywords/confocal-microscopy","display_name":"confocal microscopy","score":0.5730000138282776},{"id":"https://openalex.org/keywords/cancer-nanomedicine","display_name":"cancer nanomedicine","score":0.7440000176429749}],"concepts":[{"id":"https://openalex.org/C3018146709","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Anticancer drug","level":3,"score":0.7707432508468628},{"id":"https://openalex.org/C104819515","wikidata":"https://www.wikidata.org/wiki/Q900961","display_name":"Colloidal gold","level":3,"score":0.7686453461647034},{"id":"https://openalex.org/C171250308","wikidata":"https://www.wikidata.org/wiki/Q11468","display_name":"Nanotechnology","level":1,"score":0.7675806283950806},{"id":"https://openalex.org/C30080830","wikidata":"https://www.wikidata.org/wiki/Q169917","display_name":"Graphene","level":2,"score":0.64251309633255},{"id":"https://openalex.org/C124657808","wikidata":"https://www.wikidata.org/wiki/Q1133068","display_name":"Quantum dot","level":2,"score":0.6415013074874878},{"id":"https://openalex.org/C2779820397","wikidata":"https://www.wikidata.org/wiki/Q1392806","display_name":"Drug delivery","level":2,"score":0.6276144981384277},{"id":"https://openalex.org/C155672457","wikidata":"https://www.wikidata.org/wiki/Q61231","display_name":"Nanoparticle","level":2,"score":0.4934658110141754},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.4729421138763428},{"id":"https://openalex.org/C126511603","wikidata":"https://www.wikidata.org/wiki/Q1261145","display_name":"Targeted drug delivery","level":3,"score":0.42825233936309814},{"id":"https://openalex.org/C192562407","wikidata":"https://www.wikidata.org/wiki/Q228736","display_name":"Materials science","level":0,"score":0.4228637218475342},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.24306416511535645},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.23197254538536072}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2024-5758","doi":"https://doi.org/10.1158/1538-7445.am2024-5758","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2024-5758","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.9537000060081482,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W4393096604","https://openalex.org/W4393166825","https://openalex.org/W4393096562","https://openalex.org/W4393096827","https://openalex.org/W7202287893","https://openalex.org/W4293068259","https://openalex.org/W7036170100","https://openalex.org/W3126897531","https://openalex.org/W4391216497","https://openalex.org/W7119377218"],"abstract_inverted_index":{"Abstract":[0],"Cancer":[1,368,386],"is":[2,46,144,240,315],"a":[3,9,103,127],"global":[4],"health":[5],"challenge":[6,129],"that":[7],"has":[8,187],"profound":[10],"impact":[11,250],"on":[12,60,193,251,308],"the":[13,27,39,112,121,140,159,175,198,206,211,219,224,230,235,249,259,269,279,294,298,309,318,321,364],"lives":[14],"of":[15,30,38,67,80,105,114,123,163,218,271,297,363],"people":[16],"worldwide,":[17],"either":[18],"directly":[19],"affecting":[20],"individuals":[21],"or":[22],"their":[23],"loved":[24],"ones.":[25],"Among":[26],"various":[28,282],"types":[29],"cancer,":[31],"prostate":[32,93,194,329],"cancer":[33,45,195,220,252,310,330],"stands":[34],"out":[35],"as":[36,102,118,120,353],"one":[37],"most":[40],"prevalent":[41],"in":[42,183,232],"men.":[43],"Prostate":[44],"primarily":[47],"identified":[48],"by":[49],"symptoms":[50],"related":[51],"to":[52,63,131,190,204,215,242,247,316,324],"urinary":[53],"health.":[54],"Conventional":[55],"medical":[56],"approaches":[57],"often":[58],"rely":[59],"drug-based":[61],"treatments":[62],"address":[64],"this":[65,154,266],"form":[66],"cancer.":[68,94],"However,":[69],"like":[70],"many":[71],"treatments,":[72],"drug":[73,106,122,212,225,231,299,319,354],"therapy":[74],"comes":[75],"with":[76,167,234,262,320,349],"its":[77,132,137,326],"own":[78],"set":[79],"challenges.":[81],"In":[82,245],"our":[83],"research":[84,186],"project,":[85],"we":[86,109,156,254,276,303],"propose":[87],"an":[88],"alternative":[89],"approach":[90],"for":[91,357,367],"managing":[92],"Our":[95,185,312],"innovative":[96],"idea":[97],"centers":[98],"around":[99],"utilizing":[100],"nanoparticles":[101,260,348],"means":[104],"delivery.":[107],"Specifically,":[108],"are":[110],"investigating":[111],"use":[113],"Taxol,":[115],"also":[116,256],"known":[117],"Paclitaxel,":[119],"interest.":[124],"Taxol":[125],"possesses":[126],"significant":[128],"due":[130],"hydrophobic":[133],"nature,":[134],"which":[135,209],"hinders":[136],"circulation":[138],"within":[139],"bloodstream.":[141],"Its":[142],"solubility":[143],"extremely":[145],"low,":[146],"at":[147],"0.00025":[148],"mg":[149],"per":[150],"milliliter.":[151],"To":[152,292],"overcome":[153],"limitation,":[155],"have":[157,255,277,304],"undertaken":[158],"synthesis":[160],"and":[161,264,289,300],"integration":[162],"AuNPs":[164],"(gold":[165],"nanoparticles)":[166],"GQDs":[168],"(graphene":[169],"quantum":[170,351],"dots).":[171],"This":[172],"combination":[173],"enhances":[174],"drug's":[176],"hydrophilic":[177],"properties,":[178],"making":[179],"it":[180],"more":[181],"effective":[182],"transportation.":[184],"led":[188],"us":[189],"conduct":[191],"experiments":[192],"cells":[196,331],"(specifically":[197],"PC3":[199],"cell":[200],"line).":[201],"We":[202],"aim":[203],"compare":[205],"IC50":[207,238],"value,":[208],"represents":[210],"concentration":[213],"required":[214],"kill":[216],"50%":[217],"cells,":[221,253],"when":[222,228],"using":[223,229,281],"alone":[226],"versus":[227],"conjunction":[233],"nanoparticles.":[236],"Taxol's":[237],"value":[239],"determined":[241],"be":[243],"5.73nM.":[244],"addition":[246],"assessing":[248],"examined":[257],"how":[258,265],"interact":[261],"blood,":[263],"interaction":[267],"influences":[268],"morphology":[270],"red":[272],"blood":[273],"cells.":[274,311],"Furthermore,":[275],"characterized":[278],"system":[280],"analytical":[283],"techniques,":[284],"including":[285],"FTIR,":[286],"NMR,":[287],"Fluorescence,":[288],"UV-Vis":[290],"spectroscopy.":[291],"pinpoint":[293],"accumulation":[295],"sites":[296],"delivery":[301,355],"agents,":[302],"employed":[305],"confocal":[306],"microscopy":[307],"ultimate":[313],"objective":[314],"equip":[317],"necessary":[322],"components":[323],"facilitate":[325],"entry":[327],"into":[328],"effectively.":[332],"Citation":[333],"Format:":[334],"Fabiola":[335],"M.":[336],"Rosa":[337],"Su\u00e1rez,":[338],"Gerardo":[339],"Morell,":[340],"Brad":[341],"Weiner,":[342],"Nataniel":[343],"Medina,":[344],"Wenndy":[345],"Pantoja.":[346],"Gold":[347],"graphene":[350],"dots":[352],"platforms":[356],"anticancer":[358],"applications":[359],"[abstract].":[360],"In:":[361],"Proceedings":[362],"American":[365],"Association":[366],"Research":[369],"Annual":[370],"Meeting":[371],"2024;":[372],"Part":[373],"1":[374],"(Regular":[375],"Abstracts);":[376],"2024":[377],"Apr":[378],"5-10;":[379],"San":[380],"Diego,":[381],"CA.":[382],"Philadelphia":[383],"(PA):":[384],"AACR;":[385],"Res":[387],"2024;84(6_Suppl):Abstract":[388],"nr":[389],"5758.":[390]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-12T09:40:04.860316","created_date":"2024-03-23T00:00:00"}